<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Tumors of female reproductive system</journal-id><journal-title-group><journal-title xml:lang="en">Tumors of female reproductive system</journal-title><trans-title-group xml:lang="ru"><trans-title>Опухоли женской репродуктивной системы</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1994-4098</issn><issn publication-format="electronic">1999-8627</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">705</article-id><article-id pub-id-type="doi">10.17650/1994-4098-2020-16-1-71-77</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>GYNECOLOGY. ORIGINAL REPORTS</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ГИНЕКОЛОГИЯ. ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Effect of the dynamic curve type from the perifocal infiltration zone obtained by magnetic resonance imaging on prognosis in pelvic pathologies in women</article-title><trans-title-group xml:lang="ru"><trans-title>Влияние типа динамической кривой от зоны перифокальной инфильтрации по данным магнитно-резонансной томографии на прогноз заболевания при патологии органов таза у женщин</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1530-1327</contrib-id><name-alternatives><name xml:lang="en"><surname>Bergen</surname><given-names>T. A.</given-names></name><name xml:lang="ru"><surname>Берген</surname><given-names>Т. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2937-6322</contrib-id><name-alternatives><name xml:lang="en"><surname>Fokin</surname><given-names>V. A.</given-names></name><name xml:lang="ru"><surname>Фокин</surname><given-names>В. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1611-5000</contrib-id><name-alternatives><name xml:lang="en"><surname>Trufanov</surname><given-names>G. E.</given-names></name><name xml:lang="ru"><surname>Труфанов</surname><given-names>Г. Е.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9978-5095</contrib-id><name-alternatives><name xml:lang="en"><surname>Smagina</surname><given-names>A. V.</given-names></name><name xml:lang="ru"><surname>Смагина</surname><given-names>А. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="ru"><p>Анна Васильевна Смагина</p></bio><email>avsmagina93@gmail.com</email><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3691-2848</contrib-id><name-alternatives><name xml:lang="en"><surname>Soynov</surname><given-names>I. A.</given-names></name><name xml:lang="ru"><surname>Сойнов</surname><given-names>И. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">E.N. Meshalkin National Medical Research Center, Ministry of Health of Russia</institution></aff><aff><institution xml:lang="ru">ФГБУ «Национальный медицинский исследовательский центр им. Е.Н. Мешалкина» Минздрава России</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Almazov National Medical Research Center, Ministry of Health of Russia</institution></aff><aff><institution xml:lang="ru">ФГБУ «Национальный медицинский исследовательский центр им. В.А. Алмазова» Минздрава России</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">Novosibirsk State Medical University, Ministry of Health of Russia</institution></aff><aff><institution xml:lang="ru">ФГБОУ ВО «Новосибирский государственный медицинский университет» Минздрава России</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2020-06-09" publication-format="electronic"><day>09</day><month>06</month><year>2020</year></pub-date><volume>16</volume><issue>1</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>71</fpage><lpage>77</lpage><history><date date-type="received" iso-8601-date="2020-06-09"><day>09</day><month>06</month><year>2020</year></date><date date-type="accepted" iso-8601-date="2020-06-09"><day>09</day><month>06</month><year>2020</year></date></history><permissions><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/></permissions><self-uri xlink:href="https://ojrs.abvpress.ru/ojrs/article/view/705">https://ojrs.abvpress.ru/ojrs/article/view/705</self-uri><abstract xml:lang="en"><p><bold>The aim</bold> of the study is to evaluate the role and prognostic significance of magnetic resonance imaging (MRI) perfusion methods in prognosis of disease course and outcome based on evaluation of the perifocal infiltration zone in pelvic disorders in women.</p><p><bold>Materials and methods</bold>. Retrospective analysis of pelvic MRI data obtained using MRI system with induced magnetic field of 1.5 T was performed. The study included 530 protocols of pelvic scans in women. Two equal groups (n = 265) of patients with oncological and nononcological pathologies of pelvic organs were formed; after application of propensity score matching, each group contained 165 patients. All examination protocols included dynamic contrast enhancement. The obtained data were statistically analyzed using the Stata 13 software.</p><p><bold>Results.</bold> In the study, types of dynamic curves obtained using dynamic contrast enhancement from the perifocal infiltration zone were analyzed. There was no data showing a correlation between the type of dynamic curve from the zone of perifocal changes and disease prognosis or possibility of differential diagnosis.</p><p><bold>Conclusions.</bold> Evaluation of the perifocal infiltration zone per MRI results with intravenous contrast does not affect prognostic accuracy of the method (p &gt;0.05); contrast can be used only for differential diagnosis or evaluation of local advancement of the process.</p></abstract><trans-abstract xml:lang="ru"><p><bold>Цель исследования</bold> – оценить роль и прогностическую значимость перфузионных методик магнитно-резонансной томографии в прогнозировании течения и исхода заболевания на основании оценки зоны перифокальной инфильтрации при заболеваниях органов таза у женщин.</p><p><bold>Материалы и методы</bold>. Проведен ретроспективный анализ данных магнитно-резонансной томографии органов таза у женщин, выполненных на томографе с индукцией магнитного поля 1,5 T. В исследование включено 530 протоколов сканирования органов таза у женщин, сформированы 2 равные (n = 265) группы пациенток с опухолевой и неопухолевой патологией органов таза, после применения propensity score matching анализа в каждой группе осталось по 165 пациенток. Во все протоколы исследования была включена программа динамического контрастного усиления. Полученные данные статистически обрабатывались в пакете программ Stata 13.</p><p><bold>Результаты</bold>. В ходе исследования проанализированы типы динамических кривых, получаемых при проведении программы динамического контрастного усиления от зоны периферической инфильтрации. Не было получено данных, свидетельствующих о связи типа динамической кривой от зоны перифокальных изменений с прогнозом заболевания, а также с возможностью дифференциальной диагностики.</p><p><bold>Выводы</bold>. Оценка зоны перифокальной инфильтрации по результатам магнитно-резонансной томографии при внутривенном контрастировании не оказывает влияния на прогностическую точность метода (p &gt;0,05); контрастирование может быть использовано только для дифференциальной диагностики или оценки локальной распространенности процесса.</p></trans-abstract><kwd-group xml:lang="en"><kwd>magnetic resonance imaging</kwd><kwd>dynamic curves</kwd><kwd>contrast enhancement</kwd><kwd>perifocal infiltration</kwd><kwd>pelvic pathologies</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>магнитно-резонансная томография</kwd><kwd>динамические кривые</kwd><kwd>контрастное усиление</kwd><kwd>перифокальная инфильтрация</kwd><kwd>патология органов таза</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">1. Daun M., Fardin S., Ushinsky A. et al. PIRADS version 2 is an excellent screening tool for clinically significant prostate cancer as designated by the Validated International Society of Urological Pathology Criteria: a retrospective analysis. Curr Probl Diagn Radiol 2019. DOI: 10.1067/j.cpradiol. 2019.06.010.</mixed-citation><mixed-citation xml:lang="ru">Daun M., Fardin S., Ushinsky A. et al. PIRADS version 2 is an excellent screening tool for clinically significant prostate cancer as designated by the Validated International Society of Urological Pathology Criteria: a retrospective analysis. Curr Probl Diagn Radiol 2019. DOI: 10.1067/j.cpradiol. 2019.06.010.</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">2. Zhang X., Pang H., Dong Y. et al. A study of dynamic contrast-enhanced MR imaging features and influence factors of pelvic bone marrow in adult females. Osteoporos Int 2019;30(12):2469–76. DOI: 10.1007/s00198-019-05145-w.</mixed-citation><mixed-citation xml:lang="ru">Zhang X., Pang H., Dong Y. et al. A study of dynamic contrast-enhanced MR imaging features and influence factors of pelvic bone marrow in adult females. Osteoporos Int 2019;30(12):2469–76. DOI: 10.1007/s00198-019-05145-w.</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">3. Li H.M., Qiang J.W., Ma F.H., Zhao S.H. The value of dynamic contrast – enhanced MRI in characterizing complex ovarian tumors. J Ovarian Res 2017;10(1):4. DOI: 10.1186/s13048-017-0302-y.</mixed-citation><mixed-citation xml:lang="ru">Li H.M., Qiang J.W., Ma F.H., Zhao S.H. The value of dynamic contrast – enhanced MRI in characterizing complex ovarian tumors. J Ovarian Res 2017;10(1):4. DOI: 10.1186/s13048-017-0302-y.</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">4. Thieme S.F., Collettini F., Sehouli J. et al. Preoperative evaluation of myometrial invasion in endometrial carcinoma: prospective intra-individual comparison of magnetic resonance volumetry, diffusion-weighted and dynamic contrastenhanced magnetic resonance imaging. Anticancer Res 2018;38(8):4813–7. DOI: 10.21873/anticanres. 12791.</mixed-citation><mixed-citation xml:lang="ru">Thieme S.F., Collettini F., Sehouli J. et al. Preoperative evaluation of myometrial invasion in endometrial carcinoma: prospective intra-individual comparison of magnetic resonance volumetry, diffusion-weighted and dynamic contrastenhanced magnetic resonance imaging. Anticancer Res 2018;38(8):4813–7. DOI: 10.21873/anticanres. 12791.</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">5. Poncelet E., Delpierre C., Kerdraon O. et al. Value of dynamic contrast-enhanced MRI for tissue characterization of ovarian teratomas: correlation with histopathology. Clin Radiol 2013;68 (9):909–16. DOI: 10.1016/j.crad. 2013.03.029.</mixed-citation><mixed-citation xml:lang="ru">Poncelet E., Delpierre C., Kerdraon O. et al. Value of dynamic contrast-enhanced MRI for tissue characterization of ovarian teratomas: correlation with histopathology. Clin Radiol 2013;68 (9):909–16. DOI: 10.1016/j.crad. 2013.03.029.</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">6. Long A.G., Lundsmith E.T., Hamilton K.E. Inflammation and colorectal cancer. Curr Colorectal Cancer Rep 2017;13(4):341–51. DOI: 10.1007/s11888-017-0373-6.</mixed-citation><mixed-citation xml:lang="ru">Long A.G., Lundsmith E.T., Hamilton K.E. Inflammation and colorectal cancer. Curr Colorectal Cancer Rep 2017;13(4):341–51. DOI: 10.1007/s11888-017-0373-6.</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">7. Nougaret S., Horta M., Sala E. et al. Endometrial cancer MRI staging: updated guidelines of the European Society of urogenital radiology. Eur Radiol 2019;29(2):792–805. DOI: 10.1007/s00330-018-5515-y.</mixed-citation><mixed-citation xml:lang="ru">Nougaret S., Horta M., Sala E. et al. Endometrial cancer MRI staging: updated guidelines of the European Society of urogenital radiology. Eur Radiol 2019;29(2):792–805. DOI: 10.1007/s00330-018-5515-y.</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">8. Thomassin-Naggara I., Siles P., Balvay D. et al. MR perfusion for pelvic female imaging. Diagn Interv Imaging 2013; 94(12):1291–8. DOI: 10.1016/j.diii.2013.06.004.</mixed-citation><mixed-citation xml:lang="ru">Thomassin-Naggara I., Siles P., Balvay D. et al. MR perfusion for pelvic female imaging. Diagn Interv Imaging 2013; 94(12):1291–8. DOI: 10.1016/j.diii.2013.06.004.</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><citation-alternatives><mixed-citation xml:lang="en">9. Gity M., Parviz S., Saligheh Rad H. et al. Differentiation of benign from malignant adnexal masses by dynamic contrast-enhanced MRI (DCE-MRI): quantitative and semi-quantitative analysis at 3-Tesla MRI. Asian Pac J Cancer Prev 2019;20(4):1073–9. DOI: 10.31557/APJCP.2019.20.4.1073.</mixed-citation><mixed-citation xml:lang="ru">Gity M., Parviz S., Saligheh Rad H. et al. Differentiation of benign from malignant adnexal masses by dynamic contrast-enhanced MRI (DCE-MRI): quantitative and semi-quantitative analysis at 3-Tesla MRI. Asian Pac J Cancer Prev 2019;20(4):1073–9. DOI: 10.31557/APJCP.2019.20.4.1073.</mixed-citation></citation-alternatives></ref></ref-list></back></article>
